Business Context and Reporting Period
This Form 8-K, dated September 22, 2025, reports that Strive, Inc. (Nasdaq: ASST) has entered into an Agreement and Plan of Merger with Semler Scientific, Inc. (Semler Sci). The transaction involves a two-step merger where a Strive subsidiary will merge with Semler Sci, followed by a second merger into a Strive limited liability company. The Boards of Directors of both companies have unanimously approved the agreement.
Key Financial Metrics and Transaction Terms
The filing details the consideration for the merger but does not provide standalone financial performance metrics (revenue, profit, cash flow) for either company in this specific document.
- Exchange Ratio: Each outstanding share of Semler Sci common stock will be converted into the right to receive 21.05 shares of Strive Class A common stock.
- Equity Awards: Outstanding Semler Sci options will convert to Strive options based on the exchange ratio. Acceleration of vesting applies to non-employee directors and employees terminated without cause within six months of closing.
- Termination Fees: Semler Sci may be required to pay Strive a termination fee of $49 million in cash or Bitcoin (at Strive's election) under specific termination scenarios, including a change in recommendation by Semler Sci's Board or a willful breach of obligations.
- End Date: The agreement may be terminated if the merger is not consummated by March 22, 2026.
Material Changes and Closing Conditions
The transaction is subject to customary closing conditions, including:
- Approval by a majority of Semler Sci stockholders.
- Approval by a majority of Strive stockholders (Class A and Class B).
- Receipt of required regulatory approvals, including the expiration of waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act.
- Absence of laws or injunctions prohibiting the merger.
- No occurrence of a "Parent Material Adverse Effect" or "Company Material Adverse Effect."
Strive has agreed to appoint Eric Semler to its Board of Directors upon closing, subject to Nasdaq independence criteria.
Guidance, Risks, and Management Commentary
Management intends for the transaction to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. The filing includes extensive forward-looking statements regarding the strategic and financial benefits of the combination, which are subject to significant risks.
Key Risks Disclosed:
- Failure to satisfy closing conditions or obtain stockholder approval.
- Integration challenges and diversion of management attention.
- Dilution to Strive shareholders due to the issuance of new shares.
- Risks associated with Bitcoin treasury strategies and digital asset volatility.
- Potential for the transaction to be more expensive or take longer than anticipated.
Strive intends to file a Registration Statement on Form S-4 containing a proxy statement and prospectus for further details.
Investor Verification Checklist
- Verify the final vote results of the Semler Sci and Strive stockholder meetings.
- Monitor the status of regulatory approvals, specifically the HSR Act waiting period.
- Review the upcoming Form S-4 Registration Statement for detailed financial projections and risk factors.
- Assess the impact of the 21.05 exchange ratio on current share prices and potential dilution.
- Confirm the appointment of Eric Semler to the Strive Board of Directors post-closing.